Literature DB >> 8711653

Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia.

M T Kauppinen1, P Saikku, P Kujala, E Herva, H Syrjälä.   

Abstract

BACKGROUND: The importance of Chlamydia pneumoniae as a cause of pneumonia has remained controversial. The clinical picture of C pneumoniae and Streptococcus pneumoniae in patients admitted to hospital with community-acquired pneumonia was compared during a C pneumoniae epidemic in Finland.
METHODS: Group I consisted of 24 patients in whom serological testing and bacterial culture indicated an association with C pneumoniae only, group II comprised nine patients with both C pneumoniae and S pneumoniae, and group III consisted of 13 patients with S pneumoniae only.
RESULTS: The patients with C pneumoniae suffered from headache more frequently than the other patients (group I, 46%; group II, 11%; and group III, 15%) and had received antimicrobial treatment more often before admission to hospital (group I, 54%; groups II and III, 0%). The patients with C pneumoniae produced few good sputum samples and had suffered from respiratory symptoms longer than those with S pneumoniae (group I, 10 days; groups II and III, 4 days). C reactive protein values on admission were lowest in group I and highest in group II. The antimicrobial treatment provided in hospital covered C pneumoniae in 36% of cases in group I and 0% in group II, while S pneumoniae was covered in all patients. C pneumoniae and S pneumoniae together were associated with more severe disease and a longer stay in hospital.
CONCLUSIONS: Pneumonia caused by C pneumoniae was milder but clinically resembled that caused by S pneumoniae, and required hospital treatment even among young patients. Mixed infections were common and should be taken into account when planning antimicrobial treatment for community-acquired pneumonia. Further studies with more patients are needed to evaluate the severity of C pneumoniae pneumonia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8711653      PMCID: PMC473034          DOI: 10.1136/thx.51.2.185

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  27 in total

1.  Bacteriology of expectorated sputum with quantitative culture and wash technique compared to transtracheal aspirates.

Authors:  J G Bartlett; S M Finegold
Journal:  Am Rev Respir Dis       Date:  1978-06

Review 2.  Laboratory diagnosis of infections caused by legionellae.

Authors:  P H Edelstein
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267

3.  Hospital study of adult community-acquired pneumonia.

Authors:  J T Macfarlane; R G Finch; M J Ward; A D Macrae
Journal:  Lancet       Date:  1982-07-31       Impact factor: 79.321

4.  Rapid quantitative determination of C-reactive protein using LKB 8600 Reaction Rate Analyser.

Authors:  A Harmoinen; M Perko; P Grönroos
Journal:  Clin Chim Acta       Date:  1981-03-19       Impact factor: 3.786

5.  Pneumonia associated with the TWAR strain of Chlamydia.

Authors:  T J Marrie; J T Grayston; S P Wang; C C Kuo
Journal:  Ann Intern Med       Date:  1987-04       Impact factor: 25.391

6.  Failure of beta-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis.

Authors:  R L Sweet; J Schachter; M O Robbie
Journal:  JAMA       Date:  1983-11-18       Impact factor: 56.272

7.  Comparative features of pneumococcal, mycoplasmal, and Legionnaires' disease pneumonias.

Authors:  C M Helms; J P Viner; R H Sturm; E D Renner; W Johnson
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

8.  Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis.

Authors:  M Leinonen; J Luotonen; E Herva; K Valkonen; P H Mäkelä
Journal:  J Infect Dis       Date:  1981-12       Impact factor: 5.226

9.  An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci.

Authors:  P Saikku; S P Wang; M Kleemola; E Brander; E Rusanen; J T Grayston
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors:  J T Grayston; C C Kuo; S P Wang; J Altman
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

View more
  14 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 2.  Community acquired pneumonia: assessment and treatment.

Authors:  Caroline M Patterson; Michael R Loebinger
Journal:  Clin Med (Lond)       Date:  2012-06       Impact factor: 2.659

Review 3.  Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae.

Authors:  Wilhelmina M Huston; Christopher J Barker; Anu Chacko; Peter Timms
Journal:  J Bacteriol       Date:  2014-03-28       Impact factor: 3.490

4.  Community epidemiology of Chlamydia and Mycoplasma pneumoniae in LRTI in France over 29 months.

Authors:  Jacques Gaillat; Antoine Flahault; Bertille deBarbeyrac; Jeanne Orfila; Henri Portier; Jean-Pierre Ducroix; Christiane Bébéar; Charles Mayaud
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

5.  Community acquired pneumonia in elderly people. Addition of erythromycin is not currently justified.

Authors:  M Woodhead
Journal:  BMJ       Date:  1998-11-28

6.  A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.

Authors:  T M File; J Segreti; L Dunbar; R Player; R Kohler; R R Williams; C Kojak; A Rubin
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

7.  Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community.

Authors:  J Macfarlane; W Holmes; P Gard; R Macfarlane; D Rose; V Weston; M Leinonen; P Saikku; S Myint
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

8.  Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines.

Authors:  W S Lim; J T Macfarlane; T C Boswell; T G Harrison; D Rose; M Leinonen; P Saikku
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

9.  Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis.

Authors:  Graham D Mills; Michael R Oehley; Bruce Arrol
Journal:  BMJ       Date:  2005-01-31

10.  Aetiology and clinical presentation of mild community-acquired bacterial pneumonia.

Authors:  B Beović; B Bonac; D Kese; T Avsic-Zupanc; S Kreft; G Lesnicar; J Gorisek-Rebersek; L Rezar; S Letonja
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-09-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.